Preferred Label : lutetium Lu 177 dotatate;

Obsolete resource : false;

MeSH synonym : 177Lu-DOTATATE; DOTATATE-177Lu; (177Lu-DOTAOTyr3)octreotate; Lu-177 DOTATE; lutetium oxodotreotide Lu-177; lutetium (177Lu) oxodotreotide; (177lutetium-DOTA(O)Tyr3)octreotate;

Is substance : O;

UNII : AE221IM3BB;

Details


Main resources

You can consult :


https://ansm.sante.fr/tableau-marr/lutecium-177lu-oxodotreotide
2025
false
false
false
France
French
lutetium Lu 177 dotatate
risk management
patients guideline
lutetium Lu 177 dotatate
infusions, intravenous
radiotherapy
radiopharmaceuticals
radiopharmaceuticals
neuroendocrine tumors
lutetium (177Lu) oxodotreotide
drug information
organometallic compounds
octreotide
octreotide
organometallic compounds
octreotide

---
https://ansm.sante.fr/tableau-acces-derogatoire/lutathera
2025
false
false
false
France
French
infusions, intravenous
drug information
lutetium (177Lu) oxodotreotide
lutetium Lu 177 dotatate
radiopharmaceuticals
guidelines for drug use
Pheochromocytoma-paraganglioma
pheochromocytoma
Metastatic Lung Neuroendocrine Tumor
bronchial neoplasms
neoplasm metastasis
Thymic neuroendocrine tumor
neuroendocrine tumors
thymus neoplasms
Metastatic Thymus Neuroendocrine Neoplasm
meningioma
Somatostatin Receptor Positive
Somatostatin Receptor 2 Positive
technical report

---
https://www.has-sante.fr/jcms/p_3375407/fr/lutathera-177-lutecium-oxodotreotide-tne-pancreatiques
2022
false
false
false
France
treatment outcome
insurance, health, reimbursement
infusions, intravenous
lutetium Lu 177 dotatate
radiopharmaceuticals
lutetium (177Lu) oxodotreotide
neuroendocrine tumors
pancreatic neoplasms
Unresectable Pancreatic Neuroendocrine Neoplasm
Metastatic Pancreatic Neuroendocrine Tumor
adult
Pancreatic Neuroendocrine Tumor G2
Pancreatic Neuroendocrine Tumor G1
Somatostatin Receptor Positive
evaluation of the transparency committee

---
https://ansm.sante.fr/actualites/decision-du-27-07-2022-modification-du-cadre-de-prescription-compassionnelle-du-medicament-lutathera-370-mbq-ml-solution-pour-perfusion
2022
false
false
false
France
French
drug information
legislation, pharmacy
infusions, intravenous
lutetium Lu 177 dotatate

---
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00433
2019
false
false
false
Canada
French
drug information
drug approval
canada
treatment outcome
lutetium Lu 177 dotatate
lutetium Lu 177 dotatate
lutetium (177Lu) oxodotreotide
radiopharmaceuticals
radiopharmaceuticals
injections, intravenous
gastro-enteropancreatic neuroendocrine tumor
adult
disease progression
organometallic compounds
octreotide
octreotide
organometallic compounds
octreotide
intestinal neoplasms
pancreatic neoplasms
stomach neoplasms
neuroendocrine tumors

---
https://www.has-sante.fr/portail/jcms/c_2864194/fr/lutathera
2018
false
false
false
France
French
neuroendocrine tumors
intestinal neoplasms
radiopharmaceuticals
neoplasm metastasis
lutetium Lu 177 dotatate
lutetium
adult
infusions, intravenous
treatment outcome
lutetium (177Lu) oxodotreotide
antineoplastic agents
evaluation of the transparency committee
survival analysis
neuroendocrine tumors
intestinal neoplasms
organometallic compounds
octreotide
octreotide

---
Lutathera - lutetium (177Lu) oxodotreotide
https://www.ema.europa.eu/medicines/human/EPAR/Lutathera
2018
false
false
false
United Kingdom
French
English
neuroendocrine tumors
summary of product characteristics
package leaflet
intestinal neoplasms
radiopharmaceuticals
radiopharmaceuticals
neoplasm metastasis
lutetium Lu 177 dotatate
lutetium Lu 177 dotatate
lutetium
drug compounding
adult
infusions, intravenous
treatment outcome
lutetium (177Lu) oxodotreotide
syndication feed
drug evaluation
drug approval
europe
pregnancy
breast feeding
orphan drug production
antineoplastic agents
antineoplastic agents
gastro-enteropancreatic neuroendocrine tumor
stomach neoplasms
pancreatic neoplasms
drug interactions
product surveillance, postmarketing
drug evaluation, preclinical
organometallic compounds
octreotide
octreotide
organometallic compounds
octreotide

---
https://ansm.sante.fr/tableau-atu-rtu/lutathera-370-mbq-ml-solution-pour-perfusion
2015
false
false
false
France
French
neuroendocrine tumors
summary of product characteristics
package leaflet
guidelines for drug use
intestinal neoplasms
radiopharmaceuticals
radiopharmaceuticals
neoplasm metastasis
lutetium Lu 177 dotatate
lutetium Lu 177 dotatate
lutetium
drug compounding
adult
drug evaluation
risk assessment
infusions, intravenous
treatment outcome
lutetium (177Lu) oxodotreotide
organometallic compounds
octreotide
octreotide
organometallic compounds
octreotide

---
Nous contacter.
01/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.